Aspira Women's Health (AWH) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -474.1% | -377.2% | -180.2% | -176.3% | -85.9% | -93.1% | ||
| Changes by years, y/y, % | -93pp | +97pp | +197pp | +4pp | +90pp | -25.8% | |||
Aspira Women's Health. EBITDA margin, %
Aspira Women's Health. EBITDA margin, changes, pp
Aspira Women's Health (AWH) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -80.1% | -75.3% | -209.5% | 24.8% | -112.0% | -93.1% | |
| Changes by years, y/y, % | +137pp | +105pp | -45pp | +170pp | -32pp | |||
| Changes by quarters, q/q, % | +65pp | +5pp | -134pp | +234pp | -137pp | |||